Procter & Gamble Health Limited

PGHL

INE199A01012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:50 2024-04-26 am EDT			5-day change	1st Jan Change
4,724 ^INR	+0.08%		+0.57%	-4.48%

Feb. 06	Procter & Gamble Health Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024	CI
Feb. 06	Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024	CI

Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Executive Director, Effective March 31, 2023

March 17, 2023 at 01:11 am EDT

Procter & Gamble Health Limited announced that Mr. Amit Gupta has tendered his resignation as Executive Director of the Company Mr. Amit Gupta will be moving to a regional role within the Procter & Gamble Group.

Latest news about Procter & Gamble Health Limited

Procter & Gamble Health Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024	Feb. 06	CI
Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024	Feb. 06	CI
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 06	CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 03	CI
Procter & Gamble Hygiene to Discontinue Injection Production at Goa, Unit, India	23-09-27	MT
Procter & Gamble Health Limited Discontinues Production of Injections at its Manufacturing Plant in Goa Effective September 30, 2023	23-09-27	CI
Procter & Gamble Health's Net Profit Slumps in Fiscal Q4; Shares Dip 5%	23-08-24	MT
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-23	CI
Procter & Gamble Health Limited Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	23-08-23	CI
Procter & Gamble Health Limited Recommends Final Dividend,Payable Between November 28, 2023 to December 18, 2023	23-08-23	CI
Procter & Gamble Health Limited Announces Change in Senior Management Personnel	23-07-31	CI
Procter & Gamble India to invest $244 million to set up manufacturing facility	23-06-29	RE
Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Procter & Gamble Health Appoints CFO	23-03-17	MT
Procter & Gamble Health Limited Appoints Lokesh Chandak as Chief Financial Officer, Effective April 1, 2023	23-03-17	CI
Procter & Gamble Health's CFO Resigns	23-03-17	MT
Procter & Gamble Health Limited Announces Board Changes	23-03-17	CI
Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Executive Director, Effective March 31, 2023	23-03-17	CI
Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Chief Financial Officer, Effective March 31, 2023	23-03-17	CI
Procter & Gamble Health Limited Recommends an Interim Dividend for the Financial Year 2022-23, Payable on or Before March 05, 2023	23-02-05	CI
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-05	CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-11	CI
Procter & Gamble Health Limited Announces Intimation of Shifting of the Registered Office	22-09-14	CI
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-29	CI
Procter & Gamble Health's Fiscal Q4 Profit Climbs to $5 Million	22-08-29	MT

Chart Procter & Gamble Health Limited

Duration

Period

More charts

Company Profile

Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Companyâs brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.

Sector

Pharmaceuticals

Calendar

2024-05-01 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
PROCTER & GAMBLE HEALTH LIMITED	-4.48%	940M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B

Generic Pharmaceuticals